About Florida Cancer Specialists & Research Institute, LLC: (Homepage)
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
Connect with us:
August 08, 2024
Video
Cesar A. Perez, MD, discusses the ongoing investigation of frontline petosemtamab plus pembrolizumab in head and neck squamous cell carcinoma.
June 27, 2024
Article
The financial performance of Florida Cancer Specialists & Research Institute for the first two months of 2024 surpassed the statewide practice’s budget.
June 25, 2024
Article
The financial performance of Florida Cancer Specialists & Research Institute for the first two months of 2024 surpassed the statewide practice’s budget.
June 20, 2024
Article
Florida Cancer Specialists & Research Institute spotlights a study uncovering a new testing method to determine personalized care options in NSCLC.
June 18, 2024
Article
Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami.
June 14, 2024
Article
Florida Cancer Specialists & Research Institute physicians are participating in the FLASCO 2024 Business of Oncology Summit & Spring Session to discuss topics impacting community oncology.
June 12, 2024
Article
A case study details the importance of genomic testing in identifying cancer and guiding targeted treatment decisions that enhance overall survival.
June 09, 2024
Article
A case study showed community oncology practices emerged as the preferred site of service for cancer treatment.
June 06, 2024
Article
Florida Cancer Specialists & Research Institute, LLC announces the introduction of designated Disease SiteTeams for late-phase research & the subsequent formation of the FCS Disease Site Committee.
May 03, 2024
Article
Florida Cancer Specialists & Research Institute, LLC is calling for reform in value-based oncology care modeling.
April 29, 2024
Article
Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC was highlighted at the 2024 AACR Annual Meeting.
April 23, 2024
Article
In the wake of the cyberattack and subsequent outage of Change Healthcare, Florida Cancer Specialists & Research Institute stands resolute in its commitment to patient care and safety.
March 31, 2024
Article
FCS is pleased to announce that medical oncologist and hematologist Jacob L. Barish, MD, has joined the statewide practice.
March 27, 2024
Article
Florida Cancer Specialists & Research Institute has opened a new facility in Orange City, FL, to provide comprehensive cancer care.
February 15, 2024
Article
Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Bradley Monk, MD, FACOG, FACS has joined the statewide practice.
February 12, 2024
Article
Florida Cancer Specialists & Research Institute, LLC announces the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board.
February 09, 2024
Article
Florida Cancer Specialists & Research Institute announces their intentions to explore a new distributor and group purchasing organization partnerships.
February 08, 2024
Podcast
Drs Jacob, Van Der Wall, and Wright-Browne discuss challenges and growth opportunities they have experienced throughout their careers.
February 06, 2024
Article
The National Accreditation Program for Breast Centers has granted the Florida Cancer Specialists & Research Institute breast cancer program a 3-year accreditation.
January 25, 2024
Article
A program developed at Florida Cancer Specialists & Research Institute improves outcomes for patients prescribed selinexor for multiple myeloma.